Common Contracts

ACTAVIS PLC 4,600,000 5.500% Mandatory Convertible Preferred Shares, Series A Underwriting Agreement

Warner Chilcott LTD • March 2nd, 2015 • Pharmaceutical preparations • New York

• Company
  Warner Chilcott LTD
• Filed
  March 2nd, 2015
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

Actavis plc, a public limited company organized under the laws of Ireland (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 4,600,000 shares of 5.500% Mandatory Convertible Preferred Shares, Series A (the “Preferred Shares”), par value $0.0001 per share, of the Company (the “Underwritten Shares”). In addition, the Company proposes to issue and sell, at the option of the Underwriters, up to an additional 460,000 Preferred Shares of the Company (the “Option Shares”) solely to cover over-allotments. The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The Preferred Shares will be convertible into a variable number of ordinary shares, par value $0.0001 per share, of the Company (the “Ordinary Shares). Such Ordinary Shares into which the Shares are convertible are hereinafter referred to as the “Conversio

ACTAVIS PLC 13,194,445 Ordinary Shares Underwriting Agreement

Warner Chilcott LTD • March 2nd, 2015 • Pharmaceutical preparations • New York

• Company
  Warner Chilcott LTD
• Filed
  March 2nd, 2015
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

Actavis plc, a public limited company organized under the laws of Ireland (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 13,194,445 ordinary shares (the “Ordinary Shares”), par value $0.0001 per share, of the Company (the “Underwritten Shares”). In addition, the Company proposes to issue and sell, at the option of the Underwriters, up to an additional 1,319,444 Ordinary Shares of the Company (the “Option Shares”) solely to cover over-allotments. The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The Ordinary Shares of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.